← FDA Drug Approvals (Drugs@FDA)
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
NDA · New Drug Application · Sponsor: MACLEODS PHARMS LTD · Approved 2019-03-15
Drug application
- FDA Application #
NDA210649- Application type
- New Drug Application
- Brand name
- EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
- Generic name
- Efavirenz
- Active ingredients
- EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- MACLEODS PHARMS LTD
- First approval
- 2019-03-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown